1. Alptekin K, Akvardar Y, Kivircik Akdede BB, Dumlu K, Işik D, Pirinçci F, et al. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 2005;29:239–244. PMID:
15694230.
2. Woon PS, Chia MY, Chan WY, Sim K. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:463–468. PMID:
20109511.
3. Katschnig H. Schizophrenia and quality of life. Acta Psychiatr Scand Suppl 2000;407:33–37. PMID:
11261637.
4. Hopper K. Rethinking social recovery in schizophrenia: what a capabilities approach might offer. Soc Sci Med 2007;65:868–879. PMID:
17499900.
5. Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 2005;31:650–671. PMID:
16006593.
6. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 2007;33:1225–1237. PMID:
17204532.
7. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000;176:173–176. PMID:
10755056.
8. Addington J, Young J, Addington D. Social outcome in early psychosis. Psychol Med 2003;33:1119–1124. PMID:
12946096.
9. Gourevitch R, Abbadi S, Guelfi JD. Quality of life in schizophrenics with and without the deficit syndrome. Eur Psychiatry 2004;19:172–174. PMID:
15158926.
10. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998;155:1196–1201. PMID:
9734542.
11. Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res 2005;78:35–43. PMID:
15978781.
12. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 2000;26:119–136. PMID:
10755673.
13. Perlick DA, Rosenheck RA, Kaczynski R, Bingham S, Collins J. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophr Res 2008;99:192–199. PMID:
17851042.
14. Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 2008;165:978–987. PMID:
18450928.
15. Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y. Predictors of quality of life in major psychoses: a naturalistic follow-up study. J Clin Psychiatry 2003;64:308–315. PMID:
12716273.
16. An SK, Kang JI, Park JY, Kim KR, Lee SY, Lee E. Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia. Schizophr Res 2010;118:54–56. PMID:
20171849.
17. Kim KR, Park JY, Song DH, Koo HK, An SK. Neurocognitive performance in subjects at ultra-high risk for schizophrenia: a comparison with first-episode schizophrenia. Compr Psychiatry 2010;52:33–40. PMID:
21220063.
18. Lee SY, Namkoong K, Cho HH, Song DH, An SK. Reduced visual P300 amplitudes in individuals at ultra-high risk for psychosis and first-episode schizophrenia. Neurosci Lett 2010;486:156–160. PMID:
20858531.
19. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders: Non-Patients Edition (SCID-I/PS), Version 2. 1996,New York: New York State Psychiatric Institute, Biometrics Research.
20. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (SCID-I/P), Version 2. 1996,New York: New York State Psychiatric Institute, Biometrics Research.
21. Heinrichs DW, Hanlon TE, Carpenter WT Jr. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388–398. PMID:
6474101.
22. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: construction and validation. Psychol Rep 1982;51:663–671.
23. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull 1985;98:310–357. PMID:
3901065.
24. Rogers ES, Anthony W, Lyass A. The nature and dimensions of social support among individuals with severe mental illnesses. Community Ment Health J 2004;40:437–450. PMID:
15529477.
25. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276. PMID:
3616518.
26. Hamilton M. Rating depressive patients. J Clin Psychiatry 1980;41:21–24. PMID:
7440521.
27. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–55. PMID:
13638508.
28. Nuechterlein KH, Edell WS, Norris M, Dawson ME. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull 1986;12:408–426. PMID:
3764359.
29. Wechsler D. Wechsler Adult Intelligence Scale-Revised. 1981,New York: The Psychological Corporation.
30. Rey A. L'examen Clinique en Psychologie. 1964,Paris: Presses Universitaires de France.
31. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test Manual. 1987,San Antonio, TX: The Psychological Corporation.
32. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual-Revised and Expanded. 1993,Odessa, FL: Psychological Assessment Resources, Inc.
33. Golden CJ. Stroop Color and Word Test: Manual for Clinical and Experimental Uses. 1978,Chicago, IL: Stoelting Co.
34. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia (NCCEA). 1969,Victoria, British Columbia: Neuropsychology Laboratory, University of Victoria.
35. Ruff RM, Light RH, Evans RW. The ruff figural fluency test: a normative study with adults. Dev Neuropsychol 1987;3:37–51.
36. Reitan R. Manual for Administration of Neuropsychological Test Batteries for Adults and Children. 1979,Tucson, AZ: Reitan Neuropsychology Laboratories, Inc.
37. Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008;98:201–208. PMID:
17919890.
38. Jung HY, Hwang SS, Yi JS, Kim Y, Kim YS. Clinician-rated function and patient-rated quality of life in schizophrenia: implications of their correspondence for psychopathology and side effects. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:225–230. PMID:
19931586.
39. Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009;9:24PMID:
19445700.